medigraphic.com

2012, Number 4

<< Back Next >>

Rev Hosp Jua Mex 2012; 79 (4)

Maduración cervical con dinoprostona como estrategia para reducir el índice de cesáreas

Jiménez-Huerta J, Yescas-Mendoza S, Ortiz-Calva MI

Language: Spanish
References: 21
Page: 252-256
PDF size: 268.51 Kb.


ABSTRACT

Introduction. Dinoprostone is a series E prostaglandine, it produces relaxation on the smooth cervix muscles and stimulates the myometrium contraction. An innovative presentation is a device which produces controlled and continuous liberation in low doses to induce cervical maturation. Objective. To assess the use of the dinoprostone intravaginal device as a strategy to reduce the caesarean section rate in Hospital Juárez in Mexico City. Material and methods. A dinoprostone intravaginal device was placed into 40 patients who did not have the cervical conditions to induce labor in a period of 7 months from January to July 2009. Results. The conclusion is presented in a research work which was developed in Hospital Juárez in Mexico City with the dinoprostone intravaginal device, there were 40 births, 22 of them did following a vaginal delivery and 18 following a caesarean delivery, 56% of them did not have an indication related to the cervical conditions, 44% had as a main indication a lack labor progression. Conlusion. The resulting cervical maturation after the use of the dinoprostone intravaginal device is adequate and, according to the results of this study, it raises the Bishop raiting obtaining a higher number of births following a vaginal delivery than following a caesarean delivery.


REFERENCES

  1. Las cesáreas en México: tendencias, niveles y factores asociados. Sal Pub Mex 2004; 46: 16-22.

  2. Napoles, Mendez, et al. Experiencia con el uso del misoprostol en la preinducción e inducción del parto. Rev Cubana Obstet Ginecol 2007; 33(3).

  3. Freund J. Estadística elemental. 8a Ed. México, D. F.: Prentice- Hall Hispanoamericana; 1994.

  4. ACOG practice bulletin. Clinical management guidelines for induction of Labor, Number 107. Obstet & Gynecol 2009; 114 (2, Part 1).

  5. Valenti E. Guías de Manejo. Inducción del Trabajo de parto. Rev Hosp Mat Inf Ramón Sardá 2002; 21(2): 80-91.

  6. González L, Usandizaga M. Protocolo de inducción del parto. Palma de Mallorca, España: Hospital Universitario Son Dureta; 2006.

  7. Smith R. Parturition. N Engl J Med 2007; 356: 271-83.

  8. Induction of labor ACOG technical bulletin. Int J Gynecol Obstet 1996; 53: 65-72.

  9. Keirse M, et al. Natural Prostaglandins for induction of Labor and Preinduction cervical Ripening. Clinical Obstetrics and Gynecology 2006; 49(3).

  10. Biem S, Tumell R, Olatunbosun O, Tauh M, Biem H. A randomized controlled trial of outpatient versus inpatient labour induction with vaginal controlled-release Prostaglandin-E2: Effectiveness and satisfaction. J Obstet Gynaecol Can 2003; 25(I): 23-31.

  11. Hayashi RH. Spontaneous and induced cervical ripening. Natural dilation and effacement process and current cervical ripening techniques. J Reprod Med 1993; 38 (Suppl. 1): 66-72.

  12. Westgate J, Williams JA. Evaluation of a controlled release vaginal prostaglandin E2 pessary with retrieval system for the induction of labour. J Obstet Gynecol 1994; 14: 146-50.

  13. Pevzner L, et al. Factors predicting successful labor induction with Dinoprostone and Misoprostol vaginal inserts. Obstet Gynecol 2009; 114: 261-7.

  14. Witter FR. A randomized trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obtet Gynecol 1992; 166: 830-4.

  15. Ramsey P, et al. Cardiotocographicabnormalities associated with Dinoprostone and Misoprostol cervical ripening. Obtet Gynecol 2005; 105: 85-90.

  16. Facchinetti F, et al. Elective cervical ripening in women beyond the 290th Day of Pregnancy. A randomized trial comparing 2 Dinoprostone preparations. J Reprod Med 2007; 52: 945-9.

  17. Estivill E. Utilización de las prostaglandinas en obstetricia. Ginecología Clínica y Quirúrgica 2001; 2(1): 42-8.

  18. PROPESS. Agencia Española de Medicamentos y Productos sanitarios. Madrid, España, 2005.

  19. Strobelt N. Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low Bishop-score pregnancy. Acta Obstetriciaet Gynecologica 2006; 85: 302-5.

  20. Gümezogle AM. Misoprostol vaginal para la maduración cervical y la inducción del trabajo de parto. Revisión. Cochrane Library 2007; (4).

  21. Münch L. Métodos y Técnicas de investigación. 4a Ed. México, D.F.: Trillas; 1997, p. 99-120.




2020     |     www.medigraphic.com